Stock DNA
Pharmaceuticals & Biotechnology
CNY 87,482 Million (Large Cap)
13.00
NA
3.53%
-0.13
19.28%
2.49
Revenue and Profits:
Net Sales:
6,835 Million
(Quarterly Results - Jun 2026)
Net Profit:
2,192 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.47%
0%
-9.47%
6 Months
-22.16%
0%
-22.16%
1 Year
12.35%
0%
12.35%
2 Years
41.13%
0%
41.13%
3 Years
62.46%
0%
62.46%
4 Years
25.81%
0%
25.81%
5 Years
-9.54%
0%
-9.54%
Zhejiang NHU Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.20%
EBIT Growth (5y)
11.15%
EBIT to Interest (avg)
20.23
Debt to EBITDA (avg)
0.53
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.52
Tax Ratio
14.15%
Dividend Payout Ratio
45.25%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.31%
ROE (avg)
16.94%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
2.59
EV to EBIT
11.36
EV to EBITDA
9.26
EV to Capital Employed
2.82
EV to Sales
3.74
PEG Ratio
NA
Dividend Yield
3.40%
ROCE (Latest)
24.80%
ROE (Latest)
19.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
6,834.60
6,294.70
8.58%
Operating Profit (PBDIT) excl Other Income
3,045.10
2,730.50
11.52%
Interest
32.60
44.70
-27.07%
Exceptional Items
60.70
5.30
1,045.28%
Consolidate Net Profit
2,192.30
1,835.70
19.43%
Operating Profit Margin (Excl OI)
360.10%
341.00%
1.91%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 8.58% vs 12.22% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 19.43% vs 26.78% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
22,088.50
21,476.30
2.85%
Operating Profit (PBDIT) excl Other Income
9,854.70
9,149.30
7.71%
Interest
231.10
290.80
-20.53%
Exceptional Items
-59.20
-45.10
-31.26%
Consolidate Net Profit
6,802.10
5,896.90
15.35%
Operating Profit Margin (Excl OI)
341.70%
322.00%
1.97%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.85% vs 42.68% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 15.35% vs 116.37% in Dec 2024
About Zhejiang NHU Co. Ltd. 
Zhejiang NHU Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






